New York, NY, April 01, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Cell Viability Assays Market by Product (Consumables and Instruments), by Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Others), and by End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global cell viability assays market was valued at approximately USD 2.93 billion in 2018 and is expected to generate around USD 5.12 billion by 2025, at a CAGR of around 8.3% between 2019 and 2025.

Cell viability assay is an assay technique where the effect of a compound on cell activity is checked. This is generally used during drug development procedures to check whether the developed drug is useful for the treatment of diseases. The growing occurrence of chronic diseases is fueling the research activities to treat these diseases, which is driving the global cell viability assays market. The growing prevalence of chronic and infectious diseases is fueling the growth of the global cell viability assays market. The growing investments made by the government for drug development, increasing the cell-based research activities, and the development of technologically advanced products for cell-based assays. However, the high cost of the cell viability assay instruments may hinder the cell viability assays market in the future.

Browse through 54 Tables & 28 Figures spread over 110 Pages and in-depth TOC on “Global Cell Viability Assays Market: By Type, Industry Size, Share, Segments, Analysis and Forecast, 2018–2025”.

Request Free Sample Report of Global Cell Viability Assays Market Report @ https://www.zionmarketresearch.com/sample/cell-viability-assays-market

The global cell viability assays market is divided into product, application, and end-user. By product, the cell viability assays market is bifurcated into instruments and consumables. The consumables segment includes assay kits, reagents, and microplates. The assay kits segment include resazurin cell viability assay kits, tetrazolium reduction assay kits, calcein-AM cell viability assay kits, and others. The instruments segment includes cell imaging and analysis systems, automated cell counters, spectrophotometers, and flow cytometers. The consumables segment is anticipated to dominate the cell viability assays market globally in the future, due to the growing demand for assay kits and reagents in research activities related to a cell. The growing cell-based research is also fueling the growth of the consumables segment in global cell viability assays market. By application, the market is divided into stem cell research, clinical and diagnostic applications, basic research, drug discovery and development, and others.

The drug discovery and development segment held the largest share of the global cell viability assays market in 2018, owing to the increasing prevalence of infectious and chronic diseases. By end-user, the market is segmented into hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, academic and research institutes, and others. Pharmaceutical and biotechnological companies dominated the market in 2018, owing to the rising establishments of these companies and increasing research activities conducted by these companies.

Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/cell-viability-assays-market

By region, North America is predicted to lead the global cell viability assays market in the upcoming years, owing to an increase in the prevalence of infectious diseases and growing cell-based research activities. According to the CDC, in 2016, about 9,200 new cases of tuberculosis were registered in the U.S. The huge investments made by the government in the research sector, increasing healthcare expenditure, high quality of infrastructure in research labs and clinics, and huge establishments of major companies in North America are also fueling the region’s cell viability market. Additionally, the well-developed healthcare sector and growing technological advancements related to the products are also driving the growth of the North American cell viability assays market.

Europe acquired the second largest share of the global cell viability assays market in 2018, due to the growing cases of chronic diseases as a result of a humungous proportion of the geriatric population in the European region. In 2014, about one-third of the European population aged above 15 years was suffering from one or the other chronic disease. This high incidence of chronic diseases among the population is fueling the growth of the European market for cell viability assays. Increasing healthcare expenditure, growing research activities, rising investments made by the government in research, and development of the advanced products are also propelling the growth of the cell viability assays market.

Browse the full “Cell Viability Assays Market by Product (Consumables and Instruments), by Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Others), and by End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/cell-viability-assays-market

The Asia Pacific cell viability assays market is expected to show the highest growth in the future, owing to the presence of a large patient pool, the high prevalence of chronic and infectious diseases in developing countries, such as China and India, and huge government investments for research activities. Additionally, rapidly expanding infrastructural facilities and an increase in the number of product launches by leading companies are also fueling cell viability assays market in the Asia Pacific region.

The Middle East and Africa and Latin America are predicted to show slow growth over the forecast timespan, owing to the development of healthcare infrastructure, growing cell-based research, and increasing prevalence of chronic and infectious diseases.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/cell-viability-assays-market

Some key players of the global cell viability assays market are Bio-Rad Laboratories, Inc., GE Healthcare, PerkinElmer, Danaher Corporation, Promega Corporation, Thermo Fischer Scientific, BioTek Instruments, Biotium, Merck, Becton, Dickinson, and Company, and G-Biosciences, among others.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/3970

This report segments the global cell viability assays market as follows:

Global Cell Viability Assays Market: Product Analysis

Global Cell Viability Assays Market: Application Analysis

Global Cell Viability Assays Market: End-User Analysis

Global Cell Viability Assays Market: Regional Analysis

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com